Covered recipient · General Payments record
JOEL KRAVITZ
Allopathic & Osteopathic Physicians Emergency Medicine
General Payments · PY2022–2024
$1,116.21
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $627.97 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Mindray DS USA, Inc. | $297.61 | 1 |
| Acerta Pharma LLC | $228.57 | 3 |
| ABBVIE INC. | $71.75 | 4 |
| Fisher & Paykel Healthcare Inc | $15.88 | 1 |
| Gilead Sciences, Inc. | $14.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.97 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104107874 | CMS |
| ABBVIE INC. | $15.77 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104107876 | CMS |
| ABBVIE INC. | $16.67 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104107878 | CMS |
| ABBVIE INC. | $16.34 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104107880 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.19 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104383817 | CMS |
| AstraZeneca Pharmaceuticals LP | $146.59 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105747533 | CMS |
| AstraZeneca Pharmaceuticals LP | $66.79 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105774018 | CMS |
| Fisher & Paykel Healthcare Inc | $15.88 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143823067 | CMS |
| Gilead Sciences, Inc. | $14.16 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133737212 | CMS |
| Mindray DS USA, Inc. | $297.61 | 09/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150671814 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.